Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Pulmonology
•
Diffuse Parenchymal Lung Disease
What factors do you consider when determining whether to perform a biopsy for the diagnosis of organizing pneumonia?
Related Questions
How do you approach patients with RA and severe bronchiectasis with associated findings of UIP?
What criteria do you use to decide when to perform a BAL in hypersensitivity pneumonitis?
Do you administer immunosuppression to patients with idiopathic NSIP who have normal lung function and mild to moderate respiratory symptoms?
Do you consider administration of nintedanib or pirfenidone via enteral tube in patients unable to take PO due to recurrent aspiration?
Would you initiate antifibrotic therapy in a patient with CTD-ILD experiencing worsening symptoms and declining lung function, despite no clear evidence of fibrosis on CT scans?
What are the next steps in management of IPF exacerbation resistant to steroid therapy?
How do you determine whether to add abatacept or rituximab to the treatment regimen in patients with mild RA-ILD on methotrexate?
What is your approach to evaluating amiodarone induced interstitial pneumonitis?
What immunosuppression regimens do clinicians use in patients with progressive RB-ILD despite smoking cessation and prednisone?
What criteria do you use to determine when to start a steroid-sparing agent for hypersensitivity pneumonitis?
